Month: April 2025

NEWPORT BEACH, Calif., April 10, 2025 (GLOBE NEWSWIRE) — GivBux, Inc. (OTC: GBUX) (“GivBux” or the Company”), a publicly traded Super App and charitable giving platform, announced today that it will be featured on an upcoming episode of VERB’s “Go Fund Yourself” TV Show on Cheddar TV. The episode is scheduled to air on Thursday, April 10, 2025, at 7 PM ET. “Go Fund Yourself” is a groundbreaking interactive television series that combines entrepreneurial pitches with real-time audience participation utilizing Verb Technology Company, Inc.’s interactive video technology and know-how [NASDAQ: VERB]. Entrepreneurs present their business ideas to a panel of industry experts, known as “Titans,” and viewers have the opportunity to invest in these companies during the broadcast. The...

The global drone inspection and monitoring market is projected to reach $21.3 billion by 2027, driven by demand in industries such as oil and gas, mining, critical infrastructure, and manufacturing. Revenues from the commercialization of the jointly developed technology may reach up to $32 million by 2031  Ness Ziona, Israel, April 10, 2025 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in three-dimensional (“3D”) perception systems, announced the signing of non-binding memorandum of understanding (the “MOU”) with a prominent Indian drone manufacturer to establish a framework for collaboration as part of the India-Israel Industrial research & development (R&D) and Technological Innovation Fund (“I4F”) program. This project follows Foresight’s...

UAB “Vilniaus prekyba” being the sole shareholder of MAXIMA GRUPĖ, UAB (hereinafter – the Company) adopted resolution appointing PricewaterhouseCoopers, UAB (legal entity code 111473315) as the audit firm of the Company to perform the audit of the annual financial statements of the Company and the audit of the annual consolidated financial statements of the Company for the years 2025, 2026 and 2027. Moreover, PricewaterhouseCoopers, UAB was elected as the consolidated sustainability reporting assurance service provider for the Company to provide sustainability reporting assurance services for the period 2025–2027.

RAPALA VMC CORPORATION, Annual Financial Report, April 10, 2025 at 3:30 p.m. EET Rapala VMC Corporation’s Annual Report 2024 has been published as attachment to this release. The Annual Report contains the following sections: Board of Directors’ Report and the Financial Statements, the Corporate Governance Statement, and the Remuneration Report. The Board of Directors’ Report includes the Sustainability Statement according to the Corporate Sustainability Reporting Directive (CSRD). Rapala VMC Corporation publishes the Financial Statements in accordance with European Single Electronic Format (ESEF) reporting requirements as XHTML file. In line with the ESEF requirements, the primary statements and the notes to the consolidated financial statements have been labelled with XBRL tags. Audit firm Deloitte Oy has provided the company with an...

Roseville, Minnesota, April 10, 2025 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTC: SCTH), a leader in cybersecurity, Web3 technologies, and advanced security solutions, is pleased to announce a strategic partnership with RockerFunder LLC, a New York-based financial and marketing consultancy group. This collaboration will encompass investor relations, public relations, strategic advisory, and blockchain-focused initiatives aimed at enhancing SecureTech’s market visibility, increasing investor engagement, and fostering long-term business expansion. Through this partnership, RockerFunder will leverage its expertise in industry communications, investor outreach, and strategic market positioning to support SecureTech’s growth. Services will include exposure to institutional investors, financial analysts, registered brokers,...

Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced today that it has initiated its Phase I/IIa clinical trial at its first U.S. clinical site, the Johns Hopkins University School of Medicine. The first in human clinical trial will investigate the safety, tolerability and full pharmacokinetic profile of Clearmind’s innovative treatment, CMND-100, in Alcohol Use Disorder (AUD) patients. This study is the first clinical application of the Company’s proprietary CMND-100 platform and marks a significant milestone in the Company’s mission to provide innovative solutions for...

Report reveals best bucket list music festivals with ticket buying tips for fans CHICAGO, April 10, 2025 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today released its Trending Music Festival Guide for the 2025 music festival season. The report analyzes Vivid Seats’ ticket data to find the music festivals with the most buzz this year, how far festival fans are traveling, and essential ticket buying tips. By looking at single-day and multi-day pass purchases, Vivid Seats has ranked out the most popular music festivals that should be on everyone’s radar this year. Vivid Seats’ deep dive into trending music festivals shows the events that are most in-demand,...

Results in 17 Issued and Allowed Patent Applications Internationally with Nine Total Patent Families SOUTH SAN FRANSCISCO, Calif, April 10, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces the allowance of two patent applications submitted to the U.S. Patent and Trademark Office (USPTO), which materially expands the Company’s intellectual property portfolio. Patent Application No. 17/040,472, titled, “CELLULAR IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF,” was allowed on March 13, 2025 and provides coverage for composition of matter and methods of use coverage for the Company’s lead compound,  CER-1236. The allowed claims encompass...

MCLEAN, Va., April 10, 2025 (GLOBE NEWSWIRE) — Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces that industry veteran Reginald S. Bailey, Sr. has joined its Board of Directors, effective from the close of the Company’s recent de-SPAC transaction. Reginald S. Bailey is a high-performance operator that drives growth and profitability with complex operations. He is an accomplished entrepreneur with over 29 years of experience in C-suite roles to include CEO and COO. With a proven track record to scaling companies from startup to multimillion-dollar operations, Mr. Bailey combines entrepreneurial vision with disciplined leadership to deliver superior results for investors and stakeholders. In previous leadership roles and client engagements with George Washington...